Skip to content

Exploration and screening of novel markers for acute respiratory distress syndrome (ARDS)

The mechanistic study on the excessive immune response of ARDS and biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066182
Enrollment
Unknown
Registered
2022-11-26
Start date
2022-11-17
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute respiratory distress syndrome

Interventions

Patient study group:N/A
Case control group:N/A
Healthy control group:N/A

Sponsors

He'nan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients and their family members sign the informed consent form for the study; 2. Patients and their family members commit to comply with the study procedures and cooperate with the implementation of the whole study process; 3. Age18-80 years old; 4. Patients with ARDS whose diagnosis meets the diagnostic criteria defined by Berlin, and whose expected length of stay in the ICU is greater than 48 hours.

Exclusion criteria

Exclusion criteria: Patients with pre-existing respiratory diseases (including COPD, chronic bronchial inflammation, pulmonary fibrosis, etc.), heart failure, rheumatic immune diseases (systemic lupus erythematosus, desiccation syndrome, etc.), tumors (including lung tumors, leukemia, etc.) were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Oxygenation index;

Countries

China

Contacts

Public ContactHuanzhang Shao

He'nan Provincial People's Hospital

shiyuan@zzu.edu.cn+86 150 3719 0102

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026